Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)

被引：0

作者：

Blauvelt, Andrew ^{[1
]}

Ardern-Jones, Michael R. ^{[2
,3
]}

Bieber, Thomas ^{[4
]}

Hong, Chih-Ho ^{[5
,6
,7
]}

Chu, Chia-Yu ^{[8
,9
]}

Liu, Meng ^{[10
]}

Yang, Yang ^{[10
]}

Ladizinski, Barry ^{[10
]}

Teixeira, Henrique D. ^{[10
]}

Calimlim, Brian M. ^{[10
]}

Thyssen, Jacob P. ^{[11
]}

机构：

[1] Oregon Med Res Ctr, Portland, OR USA

[2] Univ Hosp Southampton NHS Fdn Trust, Southampton Gen Hosp, Dept Dermatol, Southampton, Hants, England

[3] Univ Southampton, Clin Expt Sci, Fac Med, Southampton, Hants, England

[4] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany

[5] Dr Chih ho Hong Med Inc, Surrey, BC, Canada

[6] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada

[7] Prob Med Res, Surrey, BC, Canada

[8] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan

[9] Natl Taiwan Univ, Coll Med, Taipei, Taiwan

[10] AbbVie Inc, N Chicago, IL USA

[11] Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

28032

引用

页码：AB171 / AB171

页数：1

共 50 条

[1] Rapid skin improvement with upadacitinib with or without topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
Simpson, Eric L.
Warren, Richard B.
Eichenfield, Lawrence F.
Katoh, Norito
Hu, Xiaofei
Zeng, Jiewei
Calimlim, Brian M.
Tenorio, Allan R.
Teixeira, Henrique D.
De Bruin-Weller, Marjolein
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB167 - AB167
[2] RAPID SYMPTOM AND SLEEP IMPROVEMENT WITH UPADACITINIB WITH OR WITHOUT TOPICAL CORTICOSTEROIDS (TCS) IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM 3 PHASE 3 STUDIES (MEASURE UP 1, MEASURE UP 2, AND AD UP)
Ardern-Jones, Michael R.
Beck, Lisa A.
Calimlim, Brian M.
Zeng, Jiewei
Chu, Alvina D.
Prajapati, Vimal H.
ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 34 - 35
[3] Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids in moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
Blauvelt, A.
Ardern-Jones, M. R.
Bieber, T.
Hong, C.
Chu, C. -Y.
Liu, M.
Yang, Y.
Ladizinski, B.
Teixeira, H. D.
Calimlim, B. M.
Thyssen, J. P.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E117 - E118
[4] RAPID QUALITY-OF-LIFE IMPROVEMENT WITH UPADACITINIB WITH OR WITHOUT TOPICAL CORTICOSTEROIDS (TCS) IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM 3 PHASE 3 STUDIES (MEASURE UP 1, MEASURE UP 2, AND AD UP)
Eyerich, Kilian
Lynde, Charles W.
Calimlim, Brian M.
Liu, Meng
Ladizinski, Barry
Warren, Richard B.
ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 34 - 34
[5] Rapid skin improvement with upadacitinib with or without topical corticosteroids in moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
Simpson, E. L.
Warren, R. B.
Eichenfield, L. F.
Katoh, N.
Hu, X.
Zeng, J.
Calimlim, B. M.
Tenorio, A. R.
Teixeira, H. D.
De Bruin-Weller, M.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E118 - E119
[6] Upadacitinib in moderate-to-severe atopic dermatitis: Combined safety analysis of phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
Guttman-Yassky, Emma
Irvine, Alan D.
Silverberg, Jonathan I.
Papp, Kim A.
Paller, Amy S.
Waterhouse, Brian
Tenorio, Allan R.
Ladizinski, Barry
Chu, Alvina D.
Liu, John
Reich, Kristian
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB129 - AB129
[7] Upadacitinib in moderate-to-severe atopic dermatitis: combined safety analysis of phase III studies (Measure Up 1, Measure Up 2 and AD Up)
Guttman-Yassky, Emma
Irvine, A. D.
Silverberg, J. I.
Papp, K. A.
Paller, A. S.
Waterhouse, B.
Tenorio, A. R.
Ladizinski, B.
Chu, A. D.
Liu, J.
Reich, Kristian
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E123 - E124
[8] Upadacitinib with or without topical corticosteroids improves health-related quality of life in adolescent and adult patients with moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
Prajapati, Vimal H.
Rosmarin, David
Shumack, Stephen
Calimlim, Brian M.
Takemoto, Shunya
Hu, Xiaofei
Ladizinski, Barry
Warren, Richard B.
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E81 - E81
[9] Improvement in Itch, Symptoms, and Quality of Life With Upadacitinib Through Week 16 in Adults and Adolescents With Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1, Measure Up 2, and AD Up)
Lio, Peter
Eichenfield, Lawrence F.
Marcoux, Danielle
Lee, Wan-Ju
Teixeira, Henrique D.
Raymundo, Eliza M.
Gamelli, Amy E.
Grada, Ayman
Hu, Xiaofei
Irvine, Alan D.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB178 - AB178
[10] 413 Improvement in itch, symptoms and quality of life with upadacitinib through week 16 in adults and adolescents with atopic dermatitis: results from phase 3 studies (Measure Up 1, Measure Up 2 and AD Up)
Lio, Peter
Eichenfield, Lawrence F.
Marcoux, Danielle
Lee, Wan-Ju
Teixeira, Henrique D.
Raymundo, Eliza M.
Gamelli, Amy E.
Grada, Ayman
Hu, Xiaofei
Irvine, Alan D.
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188

← 1 2 3 4 5 →